Unbiased Analysis of Today's Healthcare Issues
This is the topic of a recent publication with co-authors Kata Bognar, Katie Everson, Michelle Brauer, Darius Lakdawalla and Felicia Forma. The full title is Does knowledge of patient non-compliance change prescribing behavior in the real world? A claims-based analysis of patients with serious mental illness. The abstract is below, but do read the whole thing…
If you are attending AMCP Nexus in October, I am a co-author on a poster presentation titled “The Cost of Adherence Mismeasurement: A Claims-Based Analysis” co-authored with Felicia Forma, Ethan Scherer, Ainslie Hatch and Darius Lakdawalla. The presentation abstract is below and here. BACKGROUND: Payers often wish to measure how adherence to prescription drugs affects downstream…
If you are attending AMCP Nexus in October, I am a co-author on a poster presentation titled “Adherence Patterns for Oral Atypical Antipsychotics in Patients Diagnosed with Schizophrenia” co-authored with Joanna MacEwan, Felicia Forma, Ainslie Hatch and Darius Lakdawalla. The presentation abstract is below and here. BACKGROUND: Many payers rely on claims-based metrics—such as those…
Patients with schizophrenia often require medication—such as antipsychotics—to control the symptoms of their disease. However, adherence to these medications has been poor. Valenstein et al. (2004) estimate that 40% of patients are non-compliant with therapy [i.e., mediation possession ratio (MPR)<0.8]. Why are schizophrenia patients likely to be non-complient to antipsychotic therapy? One key reason is…